ERYTHROMYCIN STEARATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for erythromycin stearate and what is the scope of freedom to operate?
Erythromycin stearate
is the generic ingredient in eight branded drugs marketed by Bristol, Parke Davis, Warner Chilcott, Azurity, Ani Pharms, Lederle, Norvium Bioscience, Purepac Pharm, Watson Labs, Bristol Myers Squibb, Pfizer, and Wyeth Ayerst, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are eighteen drug master file entries for erythromycin stearate.
Summary for ERYTHROMYCIN STEARATE
| US Patents: | 0 |
| Tradenames: | 8 |
| Applicants: | 12 |
| NDAs: | 15 |
| Drug Master File Entries: | 18 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Clinical Trials: | 1 |
| Patent Applications: | 7,511 |
| Drug Prices: | Drug price trends for ERYTHROMYCIN STEARATE |
| What excipients (inactive ingredients) are in ERYTHROMYCIN STEARATE? | ERYTHROMYCIN STEARATE excipients list |
| DailyMed Link: | ERYTHROMYCIN STEARATE at DailyMed |
Recent Clinical Trials for ERYTHROMYCIN STEARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ryerson University | N/A |
| Chr Hansen A/S | N/A |
| Chr Hansen | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN STEARATE
US Patents and Regulatory Information for ERYTHROMYCIN STEARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061461-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Purepac Pharm | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061743-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 062121-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
